Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2024-11-25 00:00:00 ET · period of report 2024-11-21 · accession 0001140361-24-047756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | 2024-11-21 | RCKT | Patel Kinnari | See Remarks | S - Sale | $13.05 | -4,588 | 392.4K | -1% | -$59.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-21 | S | D | 4,588 | $13.05 | 392,395 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |